Pharmacological inhibition of Kv3 on oxidative stress-induced cataract progression

Min Seok Song1, Hun Ju Sim1, Seonmi Kang2

  • 1Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Republic of Korea.

Insights

BDS-II, a Kv3 channel blocker, shows promise in preventing and treating cataracts. This compound protects against oxidative stress-induced lens opacity and cell death, suggesting its potential as a therapeutic agent for cataractogenesis.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • Oxidative stress is a primary risk factor for cataractogenesis.
  • Kv3 channel blockers, like BDS-II, are implicated in oxidative stress-related diseases.

Purpose of the Study:

  • To investigate the protective effects of BDS-II against cataractogenesis.
  • To evaluate BDS-II's efficacy in both in vitro and in vivo cataract models.

Main Methods:

  • Assessing BDS-II's inhibition of H2O2-induced lens opacity.
  • Evaluating BDS-II's effect on glutathione (GSH) levels in a sodium selenite-induced in vivo cataract model.
  • Testing BDS-II's protective capacity against H2O2-induced cell death in human lens epithelial cells.

Main Results:

  • BDS-II significantly inhibited H2O2-induced lens opacity.
  • BDS-II treatment prevented the reduction of total GSH in an in vivo cataract model.
  • BDS-II demonstrated cytoprotective effects on human lens epithelial cells against oxidative stress.

Conclusions:

  • BDS-II exhibits significant protective effects against cataractogenesis.
  • BDS-II's mechanism involves mitigating oxidative stress and preserving glutathione levels.
  • BDS-II represents a potential pharmacological candidate for cataract therapy.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
859
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
4.1K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.6K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
19.1K